Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Aug;55(8):564–584. doi: 10.1136/ard.55.8.564

Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

G Kingsley, J Sieper
PMCID: PMC1010245  PMID: 8815821

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amor B., Dougados M., Khan M. A. Management of refractory ankylosing spondylitis and related spondyloarthropathies. Rheum Dis Clin North Am. 1995 Feb;21(1):117–128. [PubMed] [Google Scholar]
  2. Anderton S. M., van der Zee R., Noordzij A., van Eden W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol. 1994 Apr 1;152(7):3656–3664. [PubMed] [Google Scholar]
  3. Anderton S. M., van der Zee R., Prakken B., Noordzij A., van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med. 1995 Mar 1;181(3):943–952. doi: 10.1084/jem.181.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Autenrieth I. B., Beer M., Bohn E., Kaufmann S. H., Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun. 1994 Jun;62(6):2590–2599. doi: 10.1128/iai.62.6.2590-2599.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bas S., Griffais R., Kvien T. K., Glennås A., Melby K., Vischer T. L. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum. 1995 Jul;38(7):1005–1013. doi: 10.1002/art.1780380718. [DOI] [PubMed] [Google Scholar]
  6. Bas S., Griffais R., Kvien T. K., Glennås A., Melby K., Vischer T. L. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum. 1995 Jul;38(7):1005–1013. doi: 10.1002/art.1780380718. [DOI] [PubMed] [Google Scholar]
  7. Beatty W. L., Morrison R. P., Byrne G. I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994 Dec;58(4):686–699. doi: 10.1128/mr.58.4.686-699.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bessis N., Fradelizi D., Fournier C., Boissier M. C. Traitement de l'inflammation par des cytokines anti-inflammatoires: l'exemple des modèles de pathologies auto-immunes. C R Seances Soc Biol Fil. 1995;189(4):579–590. [PubMed] [Google Scholar]
  9. Bohn E., Heesemann J., Ehlers S., Autenrieth I. B. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun. 1994 Jul;62(7):3027–3032. doi: 10.1128/iai.62.7.3027-3032.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Boissier M. C., Chiocchia G., Bessis N., Hajnal J., Garotta G., Nicoletti F., Fournier C. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol. 1995 May;25(5):1184–1190. doi: 10.1002/eji.1830250508. [DOI] [PubMed] [Google Scholar]
  11. Brunner M., Larsen S., Sette A., Mitchison A. Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2Ab allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase. Eur J Immunol. 1995 Dec;25(12):3285–3289. doi: 10.1002/eji.1830251213. [DOI] [PubMed] [Google Scholar]
  12. Careless D. J., Inman R. D. Etiopathogenesis of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol. 1995 Jul;7(4):290–298. doi: 10.1097/00002281-199507000-00005. [DOI] [PubMed] [Google Scholar]
  13. Creemers M. C., van Riel P. L., Franssen M. J., van de Putte L. B., Gribnau F. W. Second-line treatment in seronegative spondylarthropathies. Semin Arthritis Rheum. 1994 Oct;24(2):71–81. doi: 10.1016/s0049-0172(05)80001-0. [DOI] [PubMed] [Google Scholar]
  14. Dougados M., vam der Linden S., Leirisalo-Repo M., Huitfeldt B., Juhlin R., Veys E., Zeidler H., Kvien T. K., Olivieri I., Dijkmans B. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum. 1995 May;38(5):618–627. doi: 10.1002/art.1780380507. [DOI] [PubMed] [Google Scholar]
  15. Feltkamp T. E., Khan M. A., Lopez de Castro J. A. The pathogenetic role of HLA-B27. Immunol Today. 1996 Jan;17(1):5–7. doi: 10.1016/0167-5699(96)80559-7. [DOI] [PubMed] [Google Scholar]
  16. Fukazawa T., Wang J., Huang F., Wen J., Tyan D., Williams K. M., Raybourne R. B., Yu D. T. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies. J Immunol. 1994 Feb 1;152(3):1190–1196. [PubMed] [Google Scholar]
  17. Gaede K. I., Baumeister E., Heesemann J. Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats. Infect Immun. 1995 Sep;63(9):3697–3701. doi: 10.1128/iai.63.9.3697-3701.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gaede K. I., Heesemann J. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats. Infect Immun. 1995 Feb;63(2):714–719. doi: 10.1128/iai.63.2.714-719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gaston J. S., Deane K. H., Jecock R. M., Pearce J. H. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol. 1996 Jan;23(1):130–136. [PubMed] [Google Scholar]
  20. Germann T., Szeliga J., Hess H., Störkel S., Podlaski F. J., Gately M. K., Schmitt E., Rüde E. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4823–4827. doi: 10.1073/pnas.92.11.4823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gripenberg-Lerche C., Skurnik M., Toivanen P. Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun. 1995 Aug;63(8):3222–3226. doi: 10.1128/iai.63.8.3222-3226.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Heesemann J., Gaede K., Autenrieth I. B. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS. 1993 Jun;101(6):417–429. [PubMed] [Google Scholar]
  23. Heesemann J., Gaede K., Autenrieth I. B. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS. 1993 Jun;101(6):417–429. [PubMed] [Google Scholar]
  24. Hermann E., Yu D. T., Meyer zum Büschenfelde K. H., Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993 Sep 11;342(8872):646–650. doi: 10.1016/0140-6736(93)91760-j. [DOI] [PubMed] [Google Scholar]
  25. Hermann E., Yu D. T., Meyer zum Büschenfelde K. H., Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993 Sep 11;342(8872):646–650. doi: 10.1016/0140-6736(93)91760-j. [DOI] [PubMed] [Google Scholar]
  26. Inman R. D., Johnston M. E., Hodge M., Falk J., Helewa A. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum. 1988 Nov;31(11):1377–1383. doi: 10.1002/art.1780311106. [DOI] [PubMed] [Google Scholar]
  27. Kaufmann S. H. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129–163. doi: 10.1146/annurev.iy.11.040193.001021. [DOI] [PubMed] [Google Scholar]
  28. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983 Dec 29;309(26):1606–1615. doi: 10.1056/NEJM198312293092604. [DOI] [PubMed] [Google Scholar]
  29. Kingsley G., Panayi G. Antigenic responses in reactive arthritis. Rheum Dis Clin North Am. 1992 Feb;18(1):49–66. [PubMed] [Google Scholar]
  30. Kvien T. K., Glennås A., Melby K., Granfors K., Andrup O., Karstensen B., Thoen J. E. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol. 1994 Jan;21(1):115–122. [PubMed] [Google Scholar]
  31. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  32. Lazarovits A. I., Karsh J. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol. 1993 Dec 1;151(11):6482–6489. [PubMed] [Google Scholar]
  33. Leirisalo-Repo M., Turunen U., Stenman S., Helenius P., Seppälä K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994 Jan;37(1):23–31. doi: 10.1002/art.1780370105. [DOI] [PubMed] [Google Scholar]
  34. Leirisalo M., Skylv G., Kousa M., Voipio-Pulkki L. M., Suoranta H., Nissilä M., Hvidman L., Nielsen E. D., Svejgaard A., Tilikainen A. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982 Mar;25(3):249–259. doi: 10.1002/art.1780250302. [DOI] [PubMed] [Google Scholar]
  35. Leirisalo M., Skylv G., Kousa M., Voipio-Pulkki L. M., Suoranta H., Nissilä M., Hvidman L., Nielsen E. D., Svejgaard A., Tilikainen A. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982 Mar;25(3):249–259. doi: 10.1002/art.1780250302. [DOI] [PubMed] [Google Scholar]
  36. Lengl-Janssen B., Strauss A. F., Steere A. C., Kamradt T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med. 1994 Dec 1;180(6):2069–2078. doi: 10.1084/jem.180.6.2069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Louis P., Eliaou J. F., Kerlan-Candon S., Pinet V., Vincent R., Clot J. Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. Immunogenetics. 1993;38(1):21–26. doi: 10.1007/BF00216386. [DOI] [PubMed] [Google Scholar]
  38. Madden D. R., Garboczi D. N., Wiley D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 1993 Nov 19;75(4):693–708. doi: 10.1016/0092-8674(93)90490-h. [DOI] [PubMed] [Google Scholar]
  39. Mattila L., Leirisalo-Repo M., Koskimies S., Granfors K., Siitonen A. Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol. 1994 Dec;33(12):1136–1141. doi: 10.1093/rheumatology/33.12.1136. [DOI] [PubMed] [Google Scholar]
  40. Mertz A. K., Daser A., Skurnik M., Wiesmüller K. H., Braun J., Appel H., Batsford S., Wu P., Distler A., Sieper J. The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity. Mol Med. 1994 Nov;1(1):44–55. [PMC free article] [PubMed] [Google Scholar]
  41. Mielants H., Veys E. M., Cuvelier C., De Vos M., Goemaere S., De Clercq L., Schatteman L., Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995 Dec;22(12):2273–2278. [PubMed] [Google Scholar]
  42. Mitchison N. A., Brunner M. C. Association of H2Ab with resistance to collagen-induced arthritis in H2-recombinant mouse strains: an allele associated with reduction of several apparently unrelated responses. Immunogenetics. 1995;41(4):239–245. doi: 10.1007/BF00172065. [DOI] [PubMed] [Google Scholar]
  43. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. doi: 10.1016/0092-8674(87)90507-1. [DOI] [PubMed] [Google Scholar]
  44. Salmi M., Andrew D. P., Butcher E. C., Jalkanen S. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med. 1995 Jan 1;181(1):137–149. doi: 10.1084/jem.181.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Salmi M., Granfors K., Leirisalo-Repo M., Hämäläinen M., MacDermott R., Leino R., Havia T., Jalkanen S. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11436–11440. doi: 10.1073/pnas.89.23.11436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schendel D. J., O'Neill G. J., Wank R. MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians. Immunogenetics. 1984;20(1):23–31. doi: 10.1007/BF00373444. [DOI] [PubMed] [Google Scholar]
  47. Sieper J., Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum. 1995 Nov;38(11):1547–1554. doi: 10.1002/art.1780381105. [DOI] [PubMed] [Google Scholar]
  48. Simon A. K., Seipelt E., Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8562–8566. doi: 10.1073/pnas.91.18.8562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stieglitz H., Lipsky P. Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope. Arthritis Rheum. 1993 Oct;36(10):1387–1391. doi: 10.1002/art.1780361010. [DOI] [PubMed] [Google Scholar]
  50. Taurog J. D., Richardson J. A., Croft J. T., Simmons W. A., Zhou M., Fernández-Sueiro J. L., Balish E., Hammer R. E. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994 Dec 1;180(6):2359–2364. doi: 10.1084/jem.180.6.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Toivanen A., Toivanen P. Epidemiologic, clinical, and therapeutic aspects of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol. 1995 Jul;7(4):279–283. doi: 10.1097/00002281-199507000-00003. [DOI] [PubMed] [Google Scholar]
  52. Toivanen A., Yli-Kerttula T., Luukkainen R., Merilahti-Palo R., Granfors K., Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol. 1993 May-Jun;11(3):301–307. [PubMed] [Google Scholar]
  53. Valtonen V. V., Leirisalo M., Pentikäinen P. J., Räsänen T., Seppälä I., Larinkari U., Ranki M., Koskimies S., Malkamäki M., Mäkelä P. H. Triggering infections in reactive arthritis. Ann Rheum Dis. 1985 Jun;44(6):399–405. doi: 10.1136/ard.44.6.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vogel U., Autenrieth I. B., Berner R., Heesemann J. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice. Microb Pathog. 1993 Jul;15(1):23–36. doi: 10.1006/mpat.1993.1054. [DOI] [PubMed] [Google Scholar]
  55. Ward M. E. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995 Nov;103(11):769–796. doi: 10.1111/j.1699-0463.1995.tb01436.x. [DOI] [PubMed] [Google Scholar]
  56. Wucherpfennig K. W., Strominger J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995 Mar 10;80(5):695–705. doi: 10.1016/0092-8674(95)90348-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. de Graeff-Meeder E. R., van Eden W., Rijkers G. T., Prakken B. J., Kuis W., Voorhorst-Ogink M. M., van der Zee R., Schuurman H. J., Helders P. J., Zegers B. J. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest. 1995 Mar;95(3):934–940. doi: 10.1172/JCI117801. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES